Monday 05 June 2023 | 17:20 Cancer vaccines poised to unlock ‘new treatment paradigm’ with Merck/Moderna data Adding an experimental mRNA-based vaccine from Moderna Inc MRNA.O and Merck & Co MRK.N (known as MSD in Europe) reduced the risk that the most deadly skin cancer ... By Reuters News Service
